A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine Leaded With Autologous Tumor Cell Lysate for Recurrent Ovarian or Primary Peritoneal Cancer.
Phase of Trial: Phase I
Latest Information Update: 25 Feb 2013
At a glance
- Drugs Dendritic cell vaccine-Northwest Biotherapeutics (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 12 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Aug 2009 Planned end date changed from 1 Nov 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 22 May 2008 Official title identified as reported by ClinicalTrials.gov.